My HPRA: Register

KEYTRUDA

50 Milligram Pdr for Soln for Infusion

Merck Sharp & Dohme LtdEU/1/15/1024/001

Main Information

Trade NameKEYTRUDA
Active SubstancesPEMBROLIZUMAB
Strength50 Milligram
Dosage FormPdr for Soln for Infusion
Licence HolderMerck Sharp & Dohme Ltd
Licence NumberEU/1/15/1024/001

Group Information

ATC CodeL01XC18 pembrolizumab

Status

Authorised/WithdrawnAuthorised
Licence Issued17/07/2015
Supply StatusSupply through pharmacies only
Dispensing StatusProduct subject to prescription which may not be renewed (A)
Marketing Status--Unknown--
Promotion StatusPromotion to Healthcare Professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back
Follow medicine

Print